Adjuvant aumolertinib in resected EGFR-mutated non-small cell lung cancer: A multiple-center real-world experience

被引：0
|
作者：
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Zhang, H. [5 ]
Lv, W. [1 ]
Hu, J. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Thorac Surg, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Dept Thorac Surg, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Wenzhou, Peoples R China
[5] Sci Grp Cent Med, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98P
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Furmonertinib as adjuvant therapy for elderly patients in resected EGFR-mutated non-small cell lung cancer: A double-center, real-world experience
    Wu, Z.
    Zhang, Q.
    He, Z.
    Ke, L.
    He, T.
    Lv, W.
    Hu, J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1655 - S1655
  • [2] Adjuvant Aumolertinib in Resected EGFR-Mutated Non-Small Cell Lung Cancer: Impact on Residual GGO Lesions
    Ma, H.
    Huang, H.
    Feng, Y.
    Chen, S.
    Li, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S559 - S560
  • [3] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated non-small cell lung cancer
    Zhang, Q.
    He, C.
    He, T.
    Wang, Y.
    Lv, W.
    Hu, J.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S73 - S73
  • [4] Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?
    Patel, Shruti R.
    Neal, Joel W.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1631 - 1635
  • [5] Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer
    Zhang, Xiaojuan
    Zhang, Mina
    Du, Xinyang
    Zhang, Guowei
    Niu, Yuanyuan
    Wei, Chunhua
    Guo, Lanwei
    Shi, Chao
    Liu, Hangfan
    Wang, Huijuan
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
    Shepherd, Annemarie F.
    Preeshagul, Isabel R.
    Shaverdian, Narek
    Wu, Abraham J.
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Rimner, Andreas
    Simone, Charles B., II
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [7] Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, H.
    Wang, L.
    Wu, Y.
    Wu, Y.
    Ma, S.
    Sen, Y.
    Zhen, H.
    Mo, Y.
    Zhang, C.
    Wang, Q.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1697 - S1697
  • [8] Adjuvant Osimertinib in Resected EGFR-Mutated Stage IBeIIIA Non-Small Cell Lung Cancer: Updated ADAURA Results
    Herbst, R. S.
    Wu, Y. -L.
    Grohe, C.
    John, T.
    Majem, M.
    Wang, J.
    Kato, T.
    Goldman, J. W.
    Kim, S. -W.
    Yu, C. -J.
    Vu, H. V.
    Mukhametshina, G.
    Akewanlop, C.
    de Marinis, F.
    Shepherd, F. A.
    Urban, D.
    Stachowiak, M.
    Bolanos, A.
    Huang, X.
    Tsuboi, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E4 - E4
  • [9] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    [J]. CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [10] Aumolertinib as Neoadjuvant Therapy for EGFR-mutated Non-Small Cell Lung Cancer: A Subcohort Analysis of the PURPOSE Trial
    Wang, Y. -Y.
    Gu, Z. -T.
    Bao, F. -C.
    Mao, T.
    Ji, C. -Y.
    Fang, W. -T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S565 - S565
12345